Ketorolac Tromethamine
Product Images NDC 55648-757

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 55648-757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 Vials Carton (Ketorolac 15 mg Sdv 25 Cartons)

25 Vials Carton (Ketorolac 15 mg Sdv 25 Cartons)
This is a label of Ketorolac Tromethamine Injection USP which indicates that it is a sterile solution for intravenous or intramuscular use. Each mL of this injection contains 15 mg ketorolac tromethamine, 10% (w/v) alcohol USP, and 6.68 mg sodium chiorde. The label includes instructions for storage and dosage but does not provide any other information.*
FDA Label Image

Vial Label (Ketorolac 15 mg Sdv Label)

Vial Label (Ketorolac 15 mg Sdv Label)
This is a description of a medication named Ketorolac Tromethamine % Injection USP, 15 mg/mL. It is manufactured by Wockhardt Limited in Mumbai, India and distributed by Wockhardt USA LLC. It comes in a single-dose vial of 1 mL and is intended for intramuscular or intravenous use only. The label warns to protect it from light. This medication is available only with a prescription.*
FDA Label Image

25 Vials Carton (Ketorolac 60 mg Sdv 25 Cartons)

25 Vials Carton (Ketorolac 60 mg Sdv 25 Cartons)
This appears to be a combination of different texts and symbols, making it not possible to generate a useful description.*
FDA Label Image

Vial Label (Ketorolac 60 mg Sdv Label)

Vial Label (Ketorolac 60 mg Sdv Label)
This is a medication called Ketorolac Tromethamine used for intramuscular injections, manufactured by Wockhardt Limited in India and distributed by Wockhardt USALLC in NJ, USA. The medication contains 60 mg of active ingredient in 2 mL single-dose vials and is only for intramuscular use. It should be protected from light. Lot number and expiration date are not visible in the given text.*
FDA Label Image

Structure (Ketorolac Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.